Kim Helen Susan
Insider CIK 1422772 · SNSS Director · ASMB Director · KITE EVP, Business Development · PRTA Director · XCUR Director · AMTI Director · AKTS Director, 10% owner · IMUC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 411,750 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 3,648,750 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 101,250 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 14,838,250 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 812,455 | $18.00 | $14.62M | 5,671,825 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 134,842 | — | $0 | 134,842 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 22,545 | $18.00 | $405.8K | 157,387 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 4,859,370 | — | $0 | 4,859,370 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2025-05-14 | 2025-05-16 | 20,183 | — | $0 | 20,183 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2024-05-15 | 2024-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2023-05-17 | 2023-05-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2022-08-31 | 2022-09-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-27 | 2021-08-27 | 701 | $30.76 | $21.6K | 575,250 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-27 | 2021-08-27 | 250 | $31.44 | $7.9K | 575,000 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-26 | 2021-08-27 | 558 | $31.01 | $17.3K | 575,951 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-26 | 2021-08-27 | 13,505 | $30.12 | $406.8K | 576,509 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-25 | 2021-08-25 | 9,478 | $30.08 | $285.1K | 590,014 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-24 | 2021-08-25 | 505 | $30.03 | $15.2K | 599,495 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-08-24 | 2021-08-25 | 3 | $30.04 | $90 | 599,492 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-07-02 | 2021-07-06 | 1,241 | $46.31 | $57.5K | 600,000 | SEC↗ |
| AMTI Applied Molecular Transpor | S Sale | 2021-07-02 | 2021-07-06 | 198,759 | $43.30 | $8.61M | 601,241 | SEC↗ |
| AMTI Applied Molecular Transpor | A Award deriv | 2021-05-18 | 2021-05-20 | 14,343 | — | $0 | 14,343 | SEC↗ |
| AMTI Applied Molecular Transpor | M Exercise deriv | 2020-07-02 | 2020-07-06 | 800,000 | — | $0 | 0 | SEC↗ |
| AMTI Applied Molecular Transpor | M Exercise | 2020-07-02 | 2020-07-06 | 800,000 | $0.02 | $16.0K | 800,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XCUR EXICURE, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 21,693 | — | $0 | 21,693 | SEC↗ |
| XCUR EXICURE, INC. | A Award deriv | 2019-06-14 | 2019-06-14 | 21,693 | — | $0 | 21,693 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XCUR EXICURE, INC. | A Award deriv | 2018-06-19 | 2018-06-21 | 21,693 | — | $0 | 21,693 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2018-03-08 | 2018-03-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 52,500 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 3,752 | $126.10 | $473.1K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 2,499 | $128.57 | $321.3K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 35,000 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 14,438 | $116.13 | $1.68M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 18,562 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 38,500 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 4,193 | $180.00 | $754.7K | 17,500 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 17,500 | — | $0 | 0 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award deriv | 2017-09-26 | 2017-09-28 | 49,649 | — | $0 | 49,649 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award deriv | 2017-09-26 | 2017-09-28 | 24,824 | — | $0 | 24,824 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award deriv | 2017-09-26 | 2017-09-28 | 24,824 | — | $0 | 24,824 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-09-25 | 2017-09-27 | 6,000 | — | $0 | 24,864 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-09-25 | 2017-09-27 | 3,171 | $179.66 | $569.7K | 21,693 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-08-10 | 2017-08-14 | 2,656 | — | $0 | 37,344 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-08-10 | 2017-08-14 | 3,595 | — | $0 | 56,407 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-10 | 2017-08-14 | 6,251 | $120.09 | $750.7K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-08-10 | 2017-08-14 | 2,656 | $51.43 | $136.6K | 24,915 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-08-10 | 2017-08-14 | 3,595 | $53.90 | $193.8K | 22,259 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-08-08 | 2017-08-10 | 79,949 | — | $0 | 60,002 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-08-08 | 2017-08-10 | 79,949 | $53.90 | $4.31M | 98,613 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 1,700 | $117.27 | $199.4K | 85,839 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 3,800 | $118.61 | $450.7K | 82,039 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 18,936 | $119.94 | $2.27M | 63,103 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 31,165 | $120.40 | $3.75M | 31,938 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 13,274 | $121.37 | $1.61M | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 11,074 | $115.02 | $1.27M | 87,539 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-07-31 | 2017-08-01 | 16,550 | — | $0 | 139,951 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-07-31 | 2017-08-01 | 10,099 | — | $0 | 40,000 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-07-31 | 2017-08-01 | 15,804 | $108.75 | $1.72M | 29,509 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-07-31 | 2017-08-01 | 2,725 | $110.55 | $301.2K | 19,336 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-07-31 | 2017-08-01 | 7,448 | $109.74 | $817.3K | 22,061 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-07-31 | 2017-08-01 | 672 | $111.60 | $75.0K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-07-31 | 2017-08-01 | 16,550 | $53.90 | $892.0K | 45,313 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-07-31 | 2017-08-01 | 10,099 | $51.43 | $519.4K | 28,763 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-06-01 | 2017-06-05 | 2,400 | — | $0 | 50,099 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-06-01 | 2017-06-05 | 2,400 | $51.43 | $123.4K | 21,064 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-06-01 | 2017-06-05 | 2,400 | $72.45 | $173.9K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-05-01 | 2017-05-03 | 2,400 | — | $0 | 156,501 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-05-01 | 2017-05-03 | 2,400 | $53.90 | $129.4K | 21,064 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-05-01 | 2017-05-03 | 2,400 | $82.12 | $197.1K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-04-03 | 2017-04-04 | 2,400 | — | $0 | 158,901 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-04-03 | 2017-04-04 | 2,400 | $53.90 | $129.4K | 21,064 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 2,400 | $81.80 | $196.3K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-03-01 | 2017-03-02 | 2,400 | — | $0 | 161,301 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 400 | $79.92 | $32.0K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 600 | $79.26 | $47.6K | 19,064 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 200 | $76.93 | $15.4K | 19,664 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 200 | $75.52 | $15.1K | 19,864 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 100 | $73.64 | $7.4K | 20,064 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 200 | $72.69 | $14.5K | 20,164 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 200 | $71.23 | $14.2K | 20,364 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 300 | $70.29 | $21.1K | 20,564 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 200 | $68.95 | $13.8K | 20,864 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-03-01 | 2017-03-02 | 2,400 | $53.90 | $129.4K | 21,064 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 31,601 | — | $0 | 52,499 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 16,299 | — | $0 | 163,701 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 300 | $72.60 | $21.8K | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 1,800 | $71.65 | $129.0K | 18,964 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 9,049 | $71.16 | $643.9K | 20,764 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 2,553 | $69.63 | $177.8K | 29,813 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 900 | $68.74 | $61.9K | 32,366 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 2,500 | $67.49 | $168.7K | 33,266 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 10,326 | $66.32 | $684.8K | 35,766 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 18,072 | $65.81 | $1.19M | 46,092 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-02-28 | 2017-03-02 | 31,601 | $51.43 | $1.63M | 50,265 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 2,400 | $63.00 | $151.2K | 64,164 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2017-02-28 | 2017-03-02 | 16,299 | $53.90 | $878.5K | 66,564 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-12-22 | 2016-12-27 | 38,500 | — | $0 | 38,500 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-12-22 | 2016-12-27 | 10,600 | — | $0 | 18,664 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2016-12-20 | 2016-12-22 | 936 | $50.86 | $47.6K | 8,064 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2016-08-15 | 2016-08-16 | 2,400 | — | $0 | 84,100 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2016-08-15 | 2016-08-16 | 2,400 | $51.43 | $123.4K | 11,400 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2016-08-15 | 2016-08-16 | 2,400 | $63.01 | $151.2K | 9,000 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise deriv | 2016-08-12 | 2016-08-16 | 33,500 | — | $0 | 86,500 | SEC↗ |
| KITE Kite Pharma, Inc. | M Exercise | 2016-08-12 | 2016-08-16 | 33,500 | $51.43 | $1.72M | 42,500 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2016-08-12 | 2016-08-16 | 33,500 | $60.08 | $2.01M | 9,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-12-17 | 2015-12-21 | 33,000 | — | $0 | 33,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2015-12-17 | 2015-12-21 | 9,200 | — | $0 | 9,200 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2015-06-30 | 2015-07-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-05-19 | 2016-08-16 | 120,000 | — | $0 | 120,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2014-06-30 | 2014-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2014-06-13 | 2014-06-17 | 40,193 | — | $0 | 40,193 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2013-09-20 | 2013-09-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2013-06-28 | 2013-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2012-09-24 | 2012-12-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2012-06-29 | 2012-07-02 | 25,000 | — | $0 | 25,000 | SEC↗ |